Biogen Leads List of Drugmakers Left to Make a Needed M&A Splash

(Bloomberg) -- Biotechnology investors who have popped corks to celebrate the wave of deals in the first half of 2019 can set their sights on the remainder of companies that have stayed passive to ...

Bloomberg Quint

Add BloombergQuint App to Home screen.